Practice Test Geeks(CNPR) Certified National Pharmaceutical Representative Practice Test
← All CNPR Flashcard Decks

Market Analysis Flashcards

7 cards from real CNPR practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Market Analysis flashcards as text

  1. What does 'market share' specifically measure in pharmaceutical sales analysis?

    Answer: A brand's percentage of total sales within a therapeutic category

    Market share measures a product's portion of total sales within its specific therapeutic category, not overall drug sales.

  2. A pharmaceutical rep notices that competitor prescriptions have increased while her product's prescriptions remained flat. What type of market data is she analyzing?

    Answer: Prescription market share trends

    Comparing relative prescription volumes between competitors over time is analysis of prescription market share trends.

  3. Which segmentation approach divides the pharmaceutical market by specific disease states or therapeutic areas?

    Answer: Therapeutic segmentation

    Therapeutic segmentation organizes the market by disease states or treatment categories, such as cardiovascular or diabetes.

  4. In pharmaceutical market analysis, 'new-to-brand' prescriptions (NBRx) best indicate:

    Answer: Patients switching from a competitor to your product

    NBRx tracks patients who are being prescribed a specific brand for the first time, often switching from a competitor or starting therapy.

  5. A pharmaceutical sales rep reviews data showing that a drug class grew 12% in total prescriptions but her brand only grew 4%. What conclusion is most accurate?

    Answer: Her brand lost market share even though sales increased

    When a brand grows slower than the overall category, it loses market share even if absolute prescription numbers increase.

  6. Which factor most directly influences a drug's formulary tier placement in managed care market analysis?

    Answer: Clinical efficacy, safety profile, and cost-effectiveness negotiations

    Formulary tier placement is primarily determined by a combination of clinical evidence, safety data, and the manufacturer's pricing negotiations with the payer.

  7. What is the primary purpose of conducting a SWOT analysis in pharmaceutical market planning?

    Answer: To evaluate internal strengths/weaknesses and external opportunities/threats

    A SWOT analysis assesses internal organizational factors and external environmental factors to inform strategic planning.